Carboplatin versus cisplatin in combination with etoposide in the first-line treatment of small cell lung cancer: a pooled analysis

BACKGROUND: Extensive-stage small cell lung cancer (ES-SCLC) is an aggressive disease with poor survival, and platinum-etoposide chemotherapy is indicated as the mainstay of treatment. In this study, we compared the efficacy and safety between the cisplatin plus etoposide (EP) and carboplatin plus e...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Shiyu, Huang, Liling, Zhen, Hongnan, Jin, Peijie, Wang, Jing, Hu, Zhihuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650295/
https://www.ncbi.nlm.nih.gov/pubmed/34876060
http://dx.doi.org/10.1186/s12885-021-09034-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650295/
https://www.ncbi.nlm.nih.gov/pubmed/34876060
http://dx.doi.org/10.1186/s12885-021-09034-6

Ejemplares similares